$TGTX 3 SEC Filings

Filed On	Filing
02 Jul 2020	Form 3: Lonial Sagar, Director No securities owned
07 May 2020	Form 3: Ra Capital MANAGEMENT, L.p., 10% owner and 3 others Holds 12,788,457 shares of Common Stock
17 Jun 2015	Form 3: Hume Daniel, Director Holds 50,000 shares of Common Stock
23 Dec 2014	Form 3: Hoberman Kenneth, Director Holds 14,223 shares of Common Stock
07 Dec 2012	Form 3: Lfb Biotechnologies S.a.s.u., 10% owner Holds 5,000,000 shares of Common Stock
07 Dec 2012	Form 3: Echelard Yann, Director No securities owned
27 Apr 2012	Form 3: Schoenebaum Mark, Director No securities owned
26 Apr 2012	Form 3: Kennedy William James, Director No securities owned
26 Apr 2012	Form 3: Charney Laurence N, Director No securities owned
09 Jan 2012	Form 3: Power Sean A, Chief Financial Officer Holds 16,875 shares of Series A Preferred Stock
09 Jan 2012	Form 3: Weiss Michael S, Director Holds 7,500,000 shares of Common Stock
09 Jan 2012	Form 3: Opus Point Partners, Llc, 10% owner Holds 248,013 shares of Series A Preferred Stock
22 Mar 2010	Form 3: Morville Malcolm, Director Holds 211,568 shares of Common Stock, $0.001 par value per share
22 Mar 2010	Form 3: Shimko David, Director Holds 42,313 shares of Common Stock, $0.001 par value per share
05 Mar 2008	Form 3: Nordic Biotech Venture Fund Ii K/S, 10% owner
11 Jul 2006	Form 3: McGuinness Michael, Chief Financial Officer Holds 0 shares of Common Stock
01 Feb 2006	Form 3: Harris Alan G, Chief Medical Officer Holds 0 shares of Common Stock
25 Apr 2005	Form 3: Abel Douglas, Director Holds 0 shares of Common Stock
17 Dec 2004	Form 3: Lipschutz Lester E, 10% owner No securities owned
08 Sep 2004	Form 3: Herskowitz Neil, Director Holds 2,500 shares of Common Stock

Comments